Precision Medicine Market Expands with Genomic Insights and Rise in Targeted Therapies | F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., AstraZeneca, Pfizer Inc., GSK plc

Precision Medicine Market reached US$98.87 billion in 2024 and is expected to reach US$329.73 billion by 2033, growing at a CAGR of 14.8% during the forecast period of 2025-2033, according to DataM Intelligence report.

Glaucoma Therapeutics Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With increasing prevalence of glaucoma, development of neuroprotective drugs, and advancements in sustained-release ocular therapies, the report delivers strategic insights for stakeholders in ophthalmology and chronic eye care from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/precision-medicine-market?ophp

Precision medicine tailors treatment and prevention strategies based on an individual's genetic profile, environment, and lifestyle. It is revolutionizing healthcare by improving outcomes, minimizing side effects, and optimizing therapeutic efficacy. The market is expanding rapidly, driven by advancements in genomics, bioinformatics, targeted therapies, and rising investment in personalized healthcare models.

Precision Medicine Market Competitors Overview:

F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., AstraZeneca, Pfizer Inc., GSK plc, Biogen, Bristol-Myers Squibb Company, Abbott, Merck & Co., Inc., and BGI, among others.

Important Industry Updates of 2023, 2024 and 2025:

✅ In April 2025, McKesson launched the Precision Care Companion (PCC) to help healthcare cancer practices integrate precision medicine into their routine practice. This consortium of industry experts provides targeted education, technology enhancements, operational best practices, and detailed analytics on biomarker testing rates for different cancer diagnoses.

✅ In January 2025, Caris Life Sciences announced a strategic and comprehensive collaboration with Ontada. Ontada specializes in oncology real-world evidence, clinical education, and point-of-care technologies. Together, the partnership aims to advance molecular research and cancer care, strengthen the healthcare delivery system, and accelerate the adoption of precision medicine.

✅ In March 2024, Mirador Therapeutics launched, securing over $400 million in funding led by ARCH Venture Partners. The startup's mission is to "transform precision medicine for immune-mediated inflammatory and fibrotic diseases," as stated in their announcement. They plan to achieve this by utilizing their proprietary Mirador360 development engine, which will facilitate the rapid advancement of various drug discovery and diagnostic programs.

Methodology and Scope

The Precision Medicine Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/precision-medicine-market?ophp

Precision Medicine Market Segments Overview:

∎ By Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Others)
∎ By Application (Diagnostics, Therapeutics, Others)

The oncology precision medicine segment leads as cancer treatment increasingly relies on genetic profiling and targeted therapies, making it the most advanced and well-funded area.

Regional Overview for Precision Medicine Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

North America dominates the glaucoma therapeutics market due to early screening programs and access to advanced treatments. Asia Pacific is the fastest growing region as an aging population, improved diagnosis, and healthcare expansion drive demand for glaucoma management.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/customize/precision-medicine-market?ophp?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Precision Medicine market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Precision Medicine market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.